DASL-HiCaP Phase 3 Trial [2022]: Update David Wise MD Prostate 9 Mins Read4 DASL-HiCaP Phase 3 Trial [2022]: Update David Wise MD Â David Wise, MD Spoke with OncologyTube about the DASL-HiCaP (randomised)…
Lutetium-177–PSMA-617 [2022]: Update David Wise MD Prostate 10 Mins Read1 Lutetium-177–PSMA-617 [2022]: Update David Wise MD  So Lutetium-PSMA-617 ((lu psma 617) prostate specific membrane antigen), we’ll call it 617…
